Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
World Journal of Emergency Surgery
Published in: World Journal of Emergency Surgery 1/2020

01-12-2020 | Antibiotic | Review

A proposal for a comprehensive approach to infections across the surgical pathway

Authors: Massimo Sartelli, Leonardo Pagani, Stefania Iannazzo, Maria Luisa Moro, Pierluigi Viale, Angelo Pan, Luca Ansaloni, Federico Coccolini, Marcello Mario D’Errico, Iris Agreiter, Giorgio Amadio Nespola, Francesco Barchiesi, Valeria Benigni, Raffaella Binazzi, Stefano Cappanera, Alessandro Chiodera, Valentina Cola, Daniela Corsi, Francesco Cortese, Massimo Crapis, Francesco Cristini, Alessandro D’Arpino, Belinda De Simone, Stefano Di Bella, Francesco Di Marzo, Abele Donati, Daniele Elisei, Massimo Fantoni, Anna Ferrari, Domitilla Foghetti, Daniela Francisci, Gianni Gattuso, Andrea Giacometti, Guido Cesare Gesuelli, Cristina Marmorale, Enrica Martini, Marcello Meledandri, Rita Murri, Daniela Padrini, Dalia Palmieri, Paola Pauri, Carla Rebagliati, Enrico Ricchizzi, Vittorio Sambri, Anna Maria Schimizzi, Walter Siquini, Loredana Scoccia, Giancarlo Scoppettuolo, Gabriele Sganga, Nadia Storti, Marcello Tavio, Giulio Toccafondi, Fabio Tumietto, Bruno Viaggi, Marco Vivarelli, Cristian Tranà, Melina Raso, Francesco Maria Labricciosa, Sameer Dhingra, Fausto Catena

Published in: World Journal of Emergency Surgery | Issue 1/2020

Login to get access

Abstract

Despite evidence supporting the effectiveness of best practices in infection prevention and management, many healthcare workers fail to implement them and evidence-based practices tend to be underused in routine practice. Prevention and management of infections across the surgical pathway should always focus on collaboration among all healthcare workers sharing knowledge of best practices. To clarify key issues in the prevention and management of infections across the surgical pathway, a multidisciplinary task force of experts convened in Ancona, Italy, on May 31, 2019, for a national meeting. This document represents the executive summary of the final statements approved by the expert panel.
Appendix
Available only for authorised users
Literature
1.
2.
3.
4.
Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP; Swissnoso. The preventable proportion of healthcare-associated infections 2005-2016: systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39:1277-1295.CrossRef
5.
Allegranzi B, Zayed B, Bischoff P, Kubilay NZ, de Jonge S, de Vries F, et al. New WHO recommendations on intraoperative and postoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16:e288–303.CrossRefPubMed
6.
Allegranzi B, Bischoff P, de Jonge S, Kubilay NZ, Zayed B, Gomes SM, et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16:e276–87.CrossRefPubMed
7.
Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:784–91.CrossRefPubMed
8.
9.
Abbas M, Tartari E, Allegranzi B, Pittet D, Harbarth S. The effect of participating in a surgical site infection (SSI) surveillance network on the time trend of SSI rates: a systematic review. Infect Control HospEpidemiol. 2017;38:1364–6.
10.
Marchi M, Pan A, Gagliotti C, Morsillo F, Parenti M, Resi D. The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011. Euro Surveill. 2014;19(21).
11.
12.
Allegranzi B, Aiken AM, Kubilay Z, Nthumba P, Barasa J, Okumu G, et al. A multimodal infection control and patient safety intervention to reduce surgical site infections in Africa: a multicentre, before-after cohort study. Lancet Infect Dis. 2018;18:507–15.PubMedCrossRef
13.
Zingg W, Storr J, Park BJ, Ahmad R, Tarrant C, Castro-Sanchez E, et al. Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1). Antimicrob Resist Infect Control. 2019;8:87.PubMedPubMedCentralCrossRef
14.
Storr J, Twyman A, Zingg W, Damani N, Kilpatrick C, Reilly J, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control. 2017;6:6.PubMedPubMedCentralCrossRef
15.
16.
17.
Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, et al. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg. 2019;14:8.PubMedPubMedCentralCrossRef
18.
19.
Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107:1011–9.PubMedCrossRef
20.
Bartlett JG. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46:1489–92.CrossRefPubMed
21.
Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, et al. Prospective randomised trial of metronidazole vs vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet. 1983;2:1043–6.CrossRefPubMed
22.
Fekety R, Silva J, Buggy B, Deery HG. Treatment of antibiotic-associated colitis with vancomycin. J Antimicrob Chemother. 1984;14:97–102.CrossRefPubMed
23.
Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422–31.CrossRefPubMed
24.
Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012;12:281–9.PubMedCrossRef
25.
Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302–7.PubMedCrossRef
26.
Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis. 2008;47:56–62.PubMedCrossRef
27.
Johnson S, Louie TJ, Gerding DN, Cornely OA, Chasan-Taber S, Fitts D, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59:345–54.PubMedCrossRef
28.
Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(Suppl 2):1–26.PubMedCrossRef
29.
Eiland EH 3rd, Sawyer AJ, Massie NL. Fidaxomicin use and clinical outcomes for Clostridium difficile-associated diarrhea. Infect Dis Clin Pract (Baltim Md). 2015;23:32–5.CrossRef
30.
Vargo CA, Bauer KA, Mangino JE, Johnston JE, Goff DA. An antimicrobial stewardship program’s real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series. Pharmacotherapy. 2014;34:901–9.PubMedCrossRef
31.
Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044–9.PubMedPubMedCentralCrossRef
32.
Bartlett JG. Bezlotoxumab - a new agent for Clostridium difficile infection. N Engl J Med. 2017;376:381–2.PubMedCrossRef
33.
Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.PubMedCrossRef
34.
Callister D, Limchaiyawat P, Eells SJ, Miller LG. Risk factors for central line-associated bloodstream infections in the era of prevention bundles. Infect Control Hosp Epidemiol. 2015;36:214–6.PubMedCrossRef
35.
Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725–32.PubMedCrossRef
36.
Entesari-Tatafi D, Orford N, Bailey MJ, Chonghaile MNI, Lamb-Jenkins J, Athan E. Effectiveness of a care bundle to reduce central line-associated bloodstream infections. Med J Aust. 2015;202:247–9.PubMedCrossRef
37.
Exline MC, Ali NA, Zikri N, Mangino JE, Torrence K, Vermillion B. Beyond the bundle - journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections. Crit Care. 2013;17:R41.PubMedPubMedCentralCrossRef
38.
Hakko E, Guvenc S, Karaman I, Cakmak A, Erdem T, Cakmakci M. Long-term sustainability of zero central-line associated bloodstream infections is possible with high compliance with care bundle elements. East Mediterr Health J. 2015;21:293–8.PubMedCrossRef
39.
McEwen SA, Collignon PJ. Antimicrobial resistance: a One Health perspective. Microbiol Spectr. 2018;6(2).
40.
Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66.PubMedPubMedCentralCrossRef
41.
42.
43.
44.
Sartelli M, Labricciosa FM, Barbadoro P, Pagani L, Ansaloni L, Brink AJ, et al. The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship-results from an international cross-sectional survey. World J Emerg Surg. 2017;12:34.PubMedPubMedCentralCrossRef
45.
Goff DA, Kullar R, Goldstein EJC, Gilchrist M, Nathwani D, Cheng AC, et al. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect Dis. 2017;17:e56–63.PubMedCrossRef
46.
Brink AJ, Messina AP, Feldman C, Richards GA, van den Bergh D. Netcare Antimicrobial Stewardship Study Alliance. From guidelines to practice - a pharmacist-driven prospective audit and feedback improvement model for peri-operative antibiotic prophylaxis in 34 South African hospitals. J Antimicrob Chemother. 2017;72:1227–34.PubMed
47.
Shafiq N, Praveen Kumar M, Gautam V, Negi H, Roat R, Malhotra S, et al. Antibiotic stewardship in a tertiary care hospital of a developing country: establishment of a system and its application in a unit-GASP Initiative. Infection. 2016;44:651–9.PubMedCrossRef
48.
Bouza E, Muñoz P, Burillo A. Role of the clinical microbiology laboratory in antimicrobial stewardship. Med Clin North Am. 2018;102:883–98.PubMedCrossRef
49.
Vandenberg O, Kozlakidis Z, Schrenzel J, Struelens MJ, Breuer J. Control of infectious diseases in the era of European clinical microbiology laboratory consolidation: new challenges and opportunities for the patient and for public health surveillance. Front Med (Lausanne). 2018;5:15.CrossRef
50.
Croxatto A, Prod’hom G, Faverjon F, Rochais Y, Greub G. Laboratory automation in clinical bacteriology: what system to choose? Clin Microbiol Infect. 2016;22:217–35.PubMedCrossRef
51.
Cantón R, Horcajada JP, Oliver A, Garbajosa PR, Vila J. Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance. Enferm Infecc Microbiol Clin. 2013;31(Suppl 4):3–11.PubMedCrossRef
52.
Tosh PK, McDonald LC. Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis. 2012;54:707–13.PubMedCrossRef
53.
Tomczyk S, Zanichelli V, Grayson ML, Twyman A, Abbas M, Pires D, et al. Control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in healthcare facilities: a systematic review and reanalysis of quasi-experimental studies. Clin Infect Dis. 2019;68:873–84.PubMedCrossRef
54.
Waters CD. Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support. Am J Health Syst Pharm. 2015;72:466–8.PubMedCrossRef
55.
von Gunten V, Reymond J-P, Beney J. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharm World Sci. 2007;29:146–63.CrossRef
56.
Dunagan WC, Woodward RS, Medoff G, Gray JL 3rd, Casabar E, Smith MD, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med. 1989;87:253–9.PubMedCrossRef
57.
Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999;29:245–52.PubMedCrossRef
58.
59.
60.
Burnett E. Effective infection prevention and control: the nurse’s role. Nurs Stand. 2018;33:68–72.CrossRefPubMed
61.
Bowater RJ, Stirling SA, Lilford RJ. Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. Ann Surg. 2009;249:551–6.PubMedCrossRef
62.
Sinha B, Van Assen S, Friedrich AW. Important issues for perioperative systemic antimicrobial prophylaxis in surgery. Curr Opin Anaesthesiol. 2014;27:377–81.PubMedCrossRef
63.
Knox MC, Edye M. Educational antimicrobial stewardship intervention ineffective in changing surgical prophylactic antibiotic prescribing. Surg Infect (Larchmt). 2016;17:224–8.PubMedCrossRef
64.
Ozgun H, Ertugrul BM, Soyder A, Ozturk B, Aydemir M. Peri-operative antibiotic prophylaxis: adherence to guidelines and effects of educational intervention. Int J Surg. 2010;8:159–63.PubMedCrossRef
65.
Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49:1496–504.PubMedCrossRef
66.
Robert J, Pean Y, Varon E, Bru JP, Bedos JP, Bertrand X, et al. Point prevalence survey of antibiotic use in French hospitals in 2009. J Antimicrob Chemother. 2012;67:1020–6.PubMedCrossRef
67.
Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69:881–91.PubMedCrossRef
68.
Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46:S19–31.PubMedCrossRef
69.
70.
Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195–283.CrossRefPubMed
71.
A global declaration on appropriate use of antimicrobial agents across the surgical pathway. Surg Infect (Larchmt). 2017;18:846–53.
72.
Huh K, Chung DR, Park HJ, Kim MJ, Lee NY, Ha YE, et al. Impact of monitoring surgical prophylactic antibiotics and a computerized decision support system on antimicrobial use and antimicrobial resistance. Am J Infect Control. 2016;44:e145–52.CrossRefPubMed
73.
Van Kasteren ME, Mannien J, Kullberg BJ, de Boer AS, Nagelkerke NJ, Ridderhof M, et al. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. J Antimicrob Chemother. 2005;56:1094–102.CrossRefPubMed
74.
Montravers P, Augustin P, Grall N, Desmard M, Allou N, Marmuse JP, et al. Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections. Crit Care. 2016;20:83.PubMedPubMedCentralCrossRef
75.
Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis. 2016;62:1009–17.CrossRefPubMed
76.
Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016;11:33.PubMedPubMedCentralCrossRef
77.
Swenson BR, Metzger R, Hedrick TL, McElearney ST, Evans HL, Smith RL, et al. Choosing antibiotics for intra-abdominal infections: what do we mean by “high risk”? Surg Infect (Larchmt). 2009;10:29–39.PubMedPubMedCentralCrossRef
78.
Sartelli M, Catena F, Abu-Zidan FM, Ansaloni L, Biffl WL, Boermeester MA, et al. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg. 2017;12:22.PubMedPubMedCentralCrossRef
79.
Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54:4851–63.PubMedPubMedCentralCrossRef
80.
Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med. 2009;180:861–6.PubMedCrossRef
81.
Castellanos-Ortega A, Suberviola B, García-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010;38:1036–43.PubMedCrossRef
82.
Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011;39:2066–71.PubMedPubMedCentralCrossRef
83.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228.CrossRefPubMedPubMedCentral
84.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–77.CrossRefPubMed
85.
Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005;3:CD001439.
86.
Mazeh H, Mizrahi I, Dior U, Simanovsky N, Shapiro M, Freund HR, et al. Role of antibiotic therapy in mild acute calculus cholecystitis: a prospective randomized controlled trial. World J Surg. 2012;36:1750–9.CrossRefPubMed
87.
Regimbeau JM, Fuks D, Pautrat K, Mauvais F, Haccart V, Msika S, et al. Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial. JAMA. 2014;312:145–54.CrossRefPubMed
88.
Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372:1996–2005.PubMedPubMedCentralCrossRef
89.
Leleu G, Aegerter P. Guidet B; Collège des Utilisateurs de Base de Donnéesen Réanimation. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care. 2002;17:168–75.CrossRefPubMed
90.
Arendrup MC, Sulims S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011;49:3300–8.PubMedPubMedCentralCrossRef
91.
Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41:1232–9.PubMedCrossRef
92.
Dean DA, Burchard KW. Surgical perspective on invasive Candida infections. World J Surg. 1998;22:127–34.PubMedCrossRef
93.
León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, et al. A bedside scoring system (Candida score) for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34:730–7.PubMedCrossRef
94.
Scudeller L, Viscoli C, Menichetti F, del Bono V, Cristini F, Tascini C, et al. An Italian consensus for invasive candidiasis management (ITALIC). Infection. 2014;42:263–79.PubMedCrossRef
95.
Mikulska M, Calandra T, Sanguinetti M, Poulain D, Viscoli C. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14:R222.PubMedPubMedCentralCrossRef
96.
Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. β-d-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis. 2011;52:750–70.PubMedCrossRef
97.
Posteraro B, Tumbarello M, De Pascale G, Liberto E, Vallecoccia MS, De Carolis E, et al. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study. J Antimicrob Chemother. 2016;71:2262-2269.CrossRef
98.
Nucci M, Anaissie E, Betts RF, Dupont BF, Wu C, Buell DN, et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis. 2010;51:295–303.PubMedCrossRef
99.
100.
Raman G, Avendano E, Berger S, Menon V. Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis. BMC Infect Dis. 2015;15:395.PubMedPubMedCentralCrossRef
101.
De Waele JJ, Dhaese S. Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient. Expert Rev Anti Infect Ther. 2019;17:89–97.CrossRefPubMed
102.
Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019;45:172–89.CrossRefPubMed
103.
Neeser O, Branche A, Mueller B, Schuetz P. How to: implement procalcitonin testing in my practice. Clin Microbiol Infect. 2019;25:1226–30.CrossRefPubMed
104.
Watkins RR, Van Duin D. Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria. Version 2. F1000Res. 2019 Jan 30 [revised 2019 Jan 1];8.
105.
Montero M, Sala M, Riu M, Belvis F, Salvado M, Grau S, et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study. Eur J Clin Microbiol Infect Dis. 2010;29:335–9.CrossRefPubMed
106.
Muilwijk J, van den Hof S, Wille JC. Associations between surgical site infection risk and hospital operation volume and surgeon operation volume among hospitals in the Dutch nosocomial infection surveillance network. Infect Control Hosp Epidemiol. 2007;28:557–63.CrossRefPubMed
107.
Beldi G, Bisch-Knaden S, Banz V, Mühlemann K, Candinas D. Impact of intraoperative behavior on surgical site infections. Am J Surg. 2009;198:157–62.CrossRefPubMed
108.
Çakmakçi M. Antibiotic stewardship programmes and the surgeon’s role. J Hosp Infect. 2015;89:264–6.CrossRefPubMed
109.
Duane TM, Zuo JX, Wolfe LG, Bearman G, Edmond MB, Lee K, et al. Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations. Am Surg. 2013;79:1269–72.PubMed
110.
Sartelli M, Labricciosa FM, Scoccia L, Bellesi J, Mazzoccanti MR, Scaloni G, et al. Non-restrictive antimicrobial stewardship program in a general and emergency surgery unit. Surg Infect (Larchmt). 2016;17:485–90.CrossRefPubMed
111.
Marshall JC. Principles of source control in the early management of sepsis. Curr Infect Dis Rev. 2010;12:345–53.CrossRef
112.
Marshall JC. al Naqbi A. Principles of source control in the management of sepsis. Crit Care Clin. 2009;25:753–68.CrossRefPubMed
113.
Jaffe TA, Nelson RC, DeLong D, Paulson EK. Practice patterns in percutaneous image-guided intra-abdominal abscess drainage: survey of academic and private practice centres. Radiology. 2004;233:750–6.CrossRefPubMed
114.
115.
Van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, et al. Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA. 2007;298:865–72.CrossRefPubMed
116.
Sartelli M, Abu-Zidan FM, Ansaloni L, Bala M, Beltrán MA, Biffl WL, et al. The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg. 2015;10:35.PubMedPubMedCentralCrossRef
117.
118.
119.
120.
Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomized trial. BMJ. 2009;338:b1374.PubMedPubMedCentralCrossRef
121.
Aabenhus R, Jensen JU, Jørgensen KJ, Hróbjartsson A, Bjerrum L. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev. 2014;11:CD010130.
122.
Gurleyik E, Gurleyik G, Unalmiser S. Accuracy of serum C-reactive protein measurements in diagnosis of acute appendicitis compared with surgeon’s clinical impression. Dis Colon Rectum. 1995;38:1270–4.CrossRefPubMed
123.
Shakhatreh HS. The accuracy of C-reactive protein in the diagnosis of acute appendicitis compared with that of clinical diagnosis. Med Arh. 2000;54:109–10.PubMed
124.
Asfar S, Safar H, Khoursheed M, Dashti H, al-Bader A. Would measurement of C-reactive protein reduce the rate of negative exploration for acute appendicitis? J R Coll Surg Edinb. 2000;45:21-24.
125.
Annane D, Maxime V, Faller JP, Mezher C, Clec’h C, Martel P, et al. Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial. BMJ Open. 2013;3:112–5.CrossRef
126.
Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, et al. Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA Intern Med. 2016;176:1266–76.CrossRefPubMed
127.
Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicenter randomised controlled trial. Lancet. 2010;375:463–74.CrossRefPubMed
128.
de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819–27.PubMedCrossRef
129.
Deliberato RO, Marra AR, Sanches PR, Martino MD, Ferreira CE, Pasternak J, et al. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis. 2013;76:266–71.PubMedCrossRef
130.
Hochreiter M, Schroeder S. Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients. Anaesthesist. 2011;60:661–73.CrossRefPubMed
131.
Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, von Spiegel T. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg. 2009;394(2):221–6.PubMedCrossRef
132.
Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13:R83.PubMedPubMedCentralCrossRef
133.
Layios N, Lambermont B, Canivet JL, Morimont P, Preiser JC, Garweg C, et al. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med. 2012;40:2304–9.PubMedCrossRef
134.
Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, et al. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med. 2013;41:2336–43.PubMedCrossRef
135.
Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008;177:498–505.PubMedCrossRef
136.
Maseda E, Suarez-de-la-Rica A, Anillo V, Tamayo E, García-Bernedo CA, Ramasco F, et al. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: a multicenter retrospective study. J Crit Care. 2015;30:537–42.PubMedCrossRef
137.
Huang TS, Huang SS, Shyu YC, Lee CH, Jwo SC, Chen PJ, et al. A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis. PLoS One. 2014;9:e90539.PubMedPubMedCentralCrossRef
138.
Mueck KM, Kao LS. Patients at high-risk for surgical site infection. Surg Infect (Larchmt). 2017;18:440–6.PubMedCrossRef
139.
Florschutz AV, Fagan RP, Matar WY, Sawyer RG, Berrios-Torres SI. Surgical siteinfection risk factors and risk stratification. J Am Acad Orthop Surg. 2015;23(Suppl):S8–S11.PubMedPubMedCentralCrossRef
140.
Bergquist JR, Thiels CA, Etzioni DA, Habermann EB, Cima RR. Failure of colorectal surgical site infection predictive models applied to an independent dataset: do they add value or just confusion? J Am Coll Surg. 2016;222:431–8.PubMedCrossRef
141.
Dumville JC, Gray TA, Walter CJ, Sharp CA, Page T. Dressings for the prevention of surgical site infection. Cochrane Database Syst Rev. 2014;9:CD003091.
142.
Dumville JC, Gray TA, Walter CJ, Sharp CA, Page T, Macefield R, et al. Dressings for the prevention of surgical site infection. Cochrane Database Syst Rev. 2016;12:CD003091.PubMed
143.
Owens P, McHugh S, Clarke-Moloney M, Healy D, Fitzpatrick F, McCormick P, et al. Improving surgical site infection prevention practices through a multifaceted educational intervention. Ir Med J. 2015;108:78–81.PubMed
144.
Metadata
Title
A proposal for a comprehensive approach to infections across the surgical pathway
Authors
Massimo Sartelli
Leonardo Pagani
Stefania Iannazzo
Maria Luisa Moro
Pierluigi Viale
Angelo Pan
Luca Ansaloni
Federico Coccolini
Marcello Mario D’Errico
Iris Agreiter
Giorgio Amadio Nespola
Francesco Barchiesi
Valeria Benigni
Raffaella Binazzi
Stefano Cappanera
Alessandro Chiodera
Valentina Cola
Daniela Corsi
Francesco Cortese
Massimo Crapis
Francesco Cristini
Alessandro D’Arpino
Belinda De Simone
Stefano Di Bella
Francesco Di Marzo
Abele Donati
Daniele Elisei
Massimo Fantoni
Anna Ferrari
Domitilla Foghetti
Daniela Francisci
Gianni Gattuso
Andrea Giacometti
Guido Cesare Gesuelli
Cristina Marmorale
Enrica Martini
Marcello Meledandri
Rita Murri
Daniela Padrini
Dalia Palmieri
Paola Pauri
Carla Rebagliati
Enrico Ricchizzi
Vittorio Sambri
Anna Maria Schimizzi
Walter Siquini
Loredana Scoccia
Giancarlo Scoppettuolo
Gabriele Sganga
Nadia Storti
Marcello Tavio
Giulio Toccafondi
Fabio Tumietto
Bruno Viaggi
Marco Vivarelli
Cristian Tranà
Melina Raso
Francesco Maria Labricciosa
Sameer Dhingra
Fausto Catena
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Antibiotic
Published in
World Journal of Emergency Surgery / Issue 1/2020
Electronic ISSN: 1749-7922
DOI
https://doi.org/10.1186/s13017-020-00295-3

Other articles of this Issue 1/2020

World Journal of Emergency Surgery 1/2020 Go to the issue

Review

Liver trauma: WSES 2020 guidelines

Research article

Trauma induced clotting factor depletion in severely injured children: a single center observational study

Review

Open necrosectomy is feasible as a last resort in selected cases with infected pancreatic necrosis: a case series and systematic literature review

Research article

Management of liver trauma in urban university hospitals in India: an observational multicentre cohort study

Correction

Correction to: The Operative management in Bariatric Acute abdomen (OBA) Survey: long-term complications of bariatric surgery and the emergency surgeon’s point of view

Research article

Using the Red Cross wound classification to predict treatment needs in children with conflict-related limb injuries: a retrospective database study